Venous thromboEmbolism Risk Profiles in Chinese hoSpitalized patiEnts (VERSE Study)
Venous Thromboembolism Risk Profiles Among Hospitalized Patients in Chinese General Hospital- a Cross-sectional Single-institution Based Study
1 other identifier
observational
27,490
1 country
1
Brief Summary
Venous thromboembolism (VTE) is a complex multifactorial disease, mainly manifested by deep vein thrombosis (DVT) and pulmonary embolism (PE). VTE events increase the length of hospitalization and treatment costs and seriously affect the quality of life of patients, so it is increasingly appreciated to identify high-risk patients with VTE and take preventive measures. The Padua prediction score (PPS) and Caprini risk assessment model (RAM) are widely used in clinical practice as common risk assessment scales in medical and surgical departments, respectively. And D-dimer levels have been considered as a well indicator to rule out acute VTE. Previous epidemiological studies on VTE have found the risk of VTE is significantly higher in hospitalized patients than in the general population and the prophylaxis decisions vary among countries, hospitals and departments, indicating current in-hospital VTE prevention strategies are far from optimal and it's imperative to regionalized control of VTE. Therefore, a single-institution-based risk profile study of in-hospital VTE patients is designed to explore current situation of VTE occurrence and predictive efficacy of widely used risk assessment models as well as D-dimer in one of the general hospitals in Beijing, China.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2020
CompletedFirst Submitted
Initial submission to the registry
September 6, 2021
CompletedFirst Posted
Study publicly available on registry
September 27, 2021
CompletedSeptember 27, 2021
September 1, 2021
1.9 years
September 6, 2021
September 23, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
The rate of in-hospital VTE
The diagnosis of VTE was confirmed as the occurrence of a critical value alert during hospitalization, which was predefined as ultrasound/radiology report of DVT or/and PE.
From June 2018 to April 2020
Caprini risk assessment model scores
Patients were stratified of VTE risk as very low risk (0), low risk (1-2), medium risk (3-4), high risk (5 and over).
Through discharge, an average of 20 days
Padua prediction score scores
Patients were stratified of VTE risk as low risk (0-3) and high risk (4 and over).
Through discharge, an average of 20 days
D-dimer values
The upper normal value 0.55mg/L FEU was used.
Through discharge, an average of 20 days
Study Arms (2)
In-hospital VTE group
In-hospital VTE group includes patients who were with a hospital stay over 3 days and new-onset of VTE during their stay. Patients who presented for VTE were excluded.
Negative group
Negative group includes patients who were with a hospital stay over 3 days and did not have a VTE during their hospital stay.
Eligibility Criteria
The investigators recruited adult inpatients attending Tsinghua Chang Gung Hospital in Beijing from June 2018 to April 2020.
You may qualify if:
- Age 18 and over, male or female
- Inpatients with a hospital stay over 3 days
- With or without new-onset of VTE during their stay
You may not qualify if:
- Patients who presented for DVT and/or PE
- Patients who were admitted in emergency department
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Tsinghua Chang Gung Hosipital
Beijing, 102218, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Weiwei Wu, MD
Beijing Tsinghua Chang Gung Hospital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 23 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 6, 2021
First Posted
September 27, 2021
Study Start
June 1, 2018
Primary Completion
April 30, 2020
Study Completion
April 30, 2020
Last Updated
September 27, 2021
Record last verified: 2021-09